Literature DB >> 8180381

Hemoglobin enhances the production of tissue factor by endothelial cells in response to bacterial endotoxin.

R I Roth1.   

Abstract

Human endothelial cells respond to bacterial endotoxin (lipopolysaccharide [LPS]) with changes that transform the endothelium into a surface with prominent procoagulant properties. Production of tissue factor (TF) in response to LPS is a major alteration that favors coagulation. Biologic activities of LPS have previously been shown to be enhanced by the presence of hemoglobin. Therefore, the ability of human hemoglobin (Hb) to modulate TF production by cultured human umbilical vein endothelial cells (HUVEC) was investigated. Cell-free Hb (10 mg/mL), either purified native (HbAo) or chemically cross-linked (alpha alpha Hb), was incubated with LPS (0.1 microgram/mL), and the mixtures then were added to HUVEC in culture. TF activity was quantified with a clotting assay and TF protein was measured with an enzyme-linked immunosorbent assay. Hb preparations greatly enhanced the production of TF activity (11- to 25-fold greater than TF produced by HUVEC alone) compared with minimal TF activity generated by LPS alone (only twofold greater than HUVEC alone). The enhancement of LPS-induced TF activity was Hb concentration-dependent over a range of 1 to 100 mg/mL. Cross-linked alpha alpha Hb also greatly enhanced the production of TF protein compared with TF protein generated by LPS alone (12-fold greater v 3.5-fold greater than HUVEC alone, respectively). The enhancement of LPS-induced TF protein was Hb concentration-dependent over a range of 0.1 to 2 mg/mL. Enhancement of TF activity by Hb required new protein synthesis. These results show that human Hb can augment the ability of LPS to induce endothelial cell TF and suggest that hemolysis associated with disseminated intravascular coagulation during sepsis may further stimulate coagulation. In addition, these results suggest a potential mechanism for generalized thrombosis in animals that has been associated with the infusion of cell-free Hb for resuscitation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8180381

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

Review 1.  Mechanisms of Hemolysis During Sepsis.

Authors:  Katharina Effenberger-Neidnicht; Matthias Hartmann
Journal:  Inflammation       Date:  2018-10       Impact factor: 4.092

Review 2.  Synergies of phosphatidylserine and protein disulfide isomerase in tissue factor activation.

Authors:  Florian Langer; Wolfram Ruf
Journal:  Thromb Haemost       Date:  2014-01-23       Impact factor: 5.249

3.  Hemoglobin increases mortality from bacterial endotoxin.

Authors:  D Su; R I Roth; M Yoshida; J Levin
Journal:  Infect Immun       Date:  1997-04       Impact factor: 3.441

4.  Oxidized hemoglobin is an endogenous proinflammatory agonist that targets vascular endothelial cells.

Authors:  Gabriela Silva; Viktoria Jeney; Angelo Chora; Rasmus Larsen; Jozsef Balla; Miguel P Soares
Journal:  J Biol Chem       Date:  2009-08-21       Impact factor: 5.157

5.  Lipopolysaccharides of Actinobacillus pleuropneumoniae bind pig hemoglobin.

Authors:  M Bélanger; C Bégin; M Jacques
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

6.  Methemoglobin-induced signaling and chemokine responses in human alveolar epithelial cells.

Authors:  Sharon Mumby; Latha Ramakrishnan; Timothy W Evans; Mark J D Griffiths; Gregory J Quinlan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-10-18       Impact factor: 5.464

Review 7.  Hemolysis Derived Products Toxicity and Endothelium: Model of the Second Hit.

Authors:  Marie Frimat; Idris Boudhabhay; Lubka T Roumenina
Journal:  Toxins (Basel)       Date:  2019-11-13       Impact factor: 4.546

8.  Bacterial lipopolysaccharide is associated with stroke.

Authors:  Marisa Hakoupian; Eva Ferino; Glen C Jickling; Hajar Amini; Boryana Stamova; Bradley P Ander; Noor Alomar; Frank R Sharp; Xinhua Zhan
Journal:  Sci Rep       Date:  2021-03-22       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.